Advertisement

Topics

LETI Pharma GmbH Company Profile

10:30 EDT 26th September 2018 | BioPortfolio

Laboratorios LETIVor rd. 80 Jahren gründete Prof. Pedro Domingo Sanjuán in Spanien das Experimentallabor für therapeutische Immunologie. LETI steht für: 'Laboratorio Experimental de Terapéutica Immunógena'. Das junge Unternehmen machte sich einen Namen als Pionier bei der Entwicklung von Antibiotika und Impfstoffen. Bereits in den frühen 40er Jahren begann es mit der Entwicklung von Präparaten zur Diagnose und Behandlung von Allergien. Wichtige Schritte auf dem Weg zu Innovationen waren: Die Gründung der Firma C.B.F. (Corporación Biológica Farmacéutica) für Forschung und Entwicklung (1985) und die Einbindung von C.B.F. in nationale Forschungs- und Entwicklungsprogramme sowie in das Eureka-Programm der Europäischen Gemeinschaft (Programmschwerpunkt: ‚Allergy Innovations').
Die Firma C.B.F. wurde später in das Unternehmen Laboratorios LETI S.A. integriert und umbenannt in C.B.F. LETI S.A.. Der Unternehmensverbund LETI mit allen Einzelgesellschaften erwirtschaftete zuletzt einen Jahresumsatz von ca. DM 43 Millionen.

Location

Mannesmannstr. 4
Witten
D-58455
Germany

Contact

Phone: 02302 / 20 28 60
Fax: 02302 / 20 28 620
Email: info@leti.de


News Articles [745 Associated News Articles listed on BioPortfolio]

DGAP-News: Novartis Pharma GmbH: GET.ON, TelePark und Circumradius gewinnen Digitalen Gesundheitspreis von Novartis und Sandoz

Novartis Pharma GmbH: GET.ON, TelePark und Circumradius gewinnen Digitalen Gesundheitspreis von Novartis und Sandoz Deutschland/Hexal DGAP-News: Novartis Pharma GmbH / Schlagwort(e): Sonstiges Nov...

Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 26062018] Prices from USD $350

Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and ...

DGAP-Adhoc: CO.DON AG: CO.DON AG zeichnet Term Sheet mit der Haemo Pharma GmbH über den Vertrieb von Spherox in Österreich (deutsch)

CO.DON AG: CO.DON AG zeichnet Term Sheet mit der Haemo Pharma GmbH über den Vertrieb von Spherox in Österreich DGAP-Ad-hoc: CO.DON AG / Schlagwort(e): Markteinführung CO.DON AG: CO.DON AG zeichnet....

Systec GmbH Introduces its new Business Partner Evidencia GmbH

Research, pharmaceuticals, life sciences and food: many laboratories rely on steam sterilizers or equipment where processes are monitored using pressure and temperature control. Thanks to our collabor...

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

Laufende Fusionskontrollverfahren: Bruker Daltonik GmbH, Bremen (D); Erwerb einer Mehrheitsbeteiligung von 80% an der HAIN LIFESCIENCE GmbH, Nehren (D);

Datum der Anmeldung:28.08.2018Aktenzeichen:B3-128/18Unternehmen:Bruker Daltonik GmbH, Bremen (D); Erwerb einer Mehrheitsbeteiligung von 80% an der HAIN LIFESCIENCE GmbH, Nehren (D);Produktmärkte:in.....

Laufende Fusionskontrollverfahren: The Paragon Fund II GmbH & Co. KG, München (D); mittelbarer Erwerb von mindestens 99% der Anteile sowie der Kontrolle über die UCB Innere Medizin GmbH & Co. KG, Monheim (D) und die UCB Primary Care GmbH, Monheim (D);

Datum der Anmeldung:07.08.2018Aktenzeichen:B3-119/18Unternehmen:The Paragon Fund II GmbH & Co. KG, München (D); mittelbarer Erwerb von mindestens 99% der Anteile sowie der Kontrolle über die UCB In....

Original-Research: CO.DON AG (von Sphene Capital GmbH): Buy

Original-Research: CO.DON AG - von Sphene Capital GmbH Einstufung von Sphene Capital GmbH zu CO.DON AG Unternehmen: CO.DON AG ISIN: DE000A1K0227 Anlass der Studie: Update Report Empfehlung: Buy se...

PubMed Articles [31 Associated PubMed Articles listed on BioPortfolio]

Cost-effectiveness analysis of blue light cystoscopy with hexylaminolevulinate in transurethral resection of the bladder.

Photodynamic diagnosis using the optical imaging agent hexaminolevulinate (HAL, Hexvix®, Ipsen Pharma GmbH, Ettlingen, Germany) as an adjunct to white light cystoscopy (WLC) during the initial transu...

Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.

Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.

Clinical trials go virtual, big pharma dives in.

Correction to: Lonoctocog Alfa: A Review in Haemophilia A.

The article Lonoctocog Alfa: A Review in Haemophilia A, written by Zaina T. Al-Salama and Lesley J. Scott, was originally published Online First without open access. After publication in volume 77...

21 Century Citizen Pharma: The FDA & Patient-Focused Product Development.

Perpetual debate regarding the delicate balance between access and innovation and the protection of the public health and safety dominate discussions of the United States Food and Drug Administration ...

Clinical Trials [122 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)

The present clinical trial will be conducted in order to compare the bioavailability of rivastigmine and to assess bioequivalence at steady-state of the Test product RID-TDS 9.5 mg/24 h (L...

Pharmacokinetic Drug Interaction Between Ezetimibe and Sirolimus After Single Dose Administration in Healthy Subjects

The purpose of this study is to confirm a significant influence of ezetimibe and sirolimus on each others pharmacokinetics

A Bioequivalence Study of Isosorbide-5-Mononitrate Extended-Release Tablets Under Fed Conditions in Healthy Subjects

The purpose of this trial is to compare the pharmacokinetic characteristics of two isosorbide -5 -mononitrate extended -release tablets 40 mg of Qilu Pharmaceutical Co., Ltd and ISMO Retar...

Fasting Bioequivalence Study of Memantinol 20 mg Tablets Versus Akatinol Memantine® 20 mg Tablets In Normal Healthy Subjects

This study are two-way crossover, open-label, single-dose, fasting, bioequivalence study of Memantinol® (JSC "GEROPHARM", Russia) 20 mg tablets versus Akatinol Memantine® (Merz Pharma Gm...

Companies [1265 Associated Companies listed on BioPortfolio]

LETI Pharma GmbH

Laboratorios LETIVor rd. 80 Jahren gründete Prof. Pedro Domingo Sanjuán in Spanien das Experimentallabor für therapeutische Immunologie. LETI steht für: 'Laboratorio Experimental de Terapéutica I...

Leti

CEA is a French research and technology public organisation, with activities in three main areas: energy, technologies for information and healthcare, and defence and security. Wi...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

CEA-Leti

CEA is a French research and technology public organisation, with activities in four main areas: energy, information technologies, healthcare technologies and defence and security...

INJEX Pharma AG

INJEX Pharma Aktiengesellschaft and its subsidiaries INJEX Pharma GmbH and INJEX Vertrieb Deutschland GmbH are specialized in the development, manufacturing and marketing in the m...

More Information about "LETI Pharma GmbH" on BioPortfolio

We have published hundreds of LETI Pharma GmbH news stories on BioPortfolio along with dozens of LETI Pharma GmbH Clinical Trials and PubMed Articles about LETI Pharma GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of LETI Pharma GmbH Companies in our database. You can also find out about relevant LETI Pharma GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...


Corporate Database Quicklinks



Searches Linking to this Company Record